1. Home
  2. DBI vs IMRX Comparison

DBI vs IMRX Comparison

Compare DBI & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Designer Brands Inc.

DBI

Designer Brands Inc.

HOLD

Current Price

$6.93

Market Cap

314.7M

ML Signal

HOLD

Logo Immuneering Corporation

IMRX

Immuneering Corporation

HOLD

Current Price

$4.93

Market Cap

366.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DBI
IMRX
Founded
1991
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
314.7M
366.1M
IPO Year
1991
2021

Fundamental Metrics

Financial Performance
Metric
DBI
IMRX
Price
$6.93
$4.93
Analyst Decision
Hold
Strong Buy
Analyst Count
2
5
Target Price
$7.25
$17.20
AVG Volume (30 Days)
879.9K
1.8M
Earning Date
03-19-2026
03-19-2026
Dividend Yield
2.88%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,892,654,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.87
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.18
$1.10
52 Week High
$8.75
$10.08

Technical Indicators

Market Signals
Indicator
DBI
IMRX
Relative Strength Index (RSI) 46.84 41.35
Support Level $6.02 $4.51
Resistance Level $7.51 $5.02
Average True Range (ATR) 0.54 0.35
MACD -0.07 0.01
Stochastic Oscillator 33.13 23.33

Price Performance

Historical Comparison
DBI
IMRX

About DBI Designer Brands Inc.

Designer Brands Inc is a designer, producer, and retailer of footwear and accessories. The company operates in three reportable segments: the U.S. Retail segment, the Canada Retail segment and the Brand Portfolio segment. The U.S. Retail segment operates the DSW Designer Shoe Warehouse banner through its direct-to-consumer U.S. stores and e-commerce site. The Canada Retail segment operates The Shoe Company and DSW banners through its direct-to-consumer Canada stores and e-commerce sites. The Brand Portfolio segment earns revenue from the sale of wholesale products to retailers, commissions for serving retailers as the design and buying agent for products under private labels, and the sale of branded products through its direct-to-consumer e-commerce sites.

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

Share on Social Networks: